Introduction
Background and rationale
Objectives
Methods
Study design
Eligibility criteria
Inclusion criteria | Exclusion criteria |
---|---|
Diagnosis of MCI due to AD or AD dementia based on patient history, neuropsychological assessment, and neuroimaging within the last 2 years | Meeting the additional criteria of a non-AD neurodegenerative disease (vascular co-pathology is permitted) |
Presence of NPS; ≥ 1 symptoms on NPI-Q | Legally incapable to give informed consent |
MMSE score > 15 | Evidence of current delirium or previous delirium |
Patients need to be community-dwelling | Primary (premorbid) psychiatric disorders that could better explain the manifestation of NPS |
Availability of a reliable informant | Participating in a clinical (medication) trial |
Recruitment
Interventions
Control group
Intervention group
Outcome measures
Outcome | Measure | Purpose | Respondent | Time of assessment |
---|---|---|---|---|
Demographic characteristics | For example, age, education, sex, ethnicity, relation to caregiver | Descriptive, covariate, moderator | Patient and caregiver | T0 |
Clinical characteristics | For example, diagnosis, AD biomarkers, disease duration | Descriptive, moderator | Patient and caregiver | T0* |
Disease severity | CDR [57] | Descriptive, moderator | Patient | T0*, T2 |
Cognitive status | MMSE [58] | Descriptive, moderator | Patient | T0*, T2 |
Cognitive functioning | Descriptive, moderator | Patient | T0* | |
Functional abilities | A-IADL-Q [66] | Descriptive, moderator | Caregiver | T0, T2 |
Psychotropic medications | Brown bag review [20] | Descriptive, secondary outcome | Caregiver | T0, T1, T2 |
Comorbidities | CIRS-G [50] | Descriptive | Patient | T0, T2 |
Quality of life patient | QoL-AD [67] | Primary outcome | Patient and caregiver | T0, T1, T2 |
Quality of life caregiver | CarerQol-7D [53] | Primary outcome | Caregiver | T0, T1, T2 |
Caregiver burden | Perseverance time [68] | Secondary outcome | Caregiver | T0, T1, T2 |
Caregiver competence managing NPS | Additional NPI-Q item [69] | Secondary outcome | Caregiver | T0, T1, T2 |
Cost-effectiveness | Secondary outcome | Patient Caregiver | T0, T1, T2 | |
NPS prevalence, severity, and distress | NPI-Q [44] | Secondary outcome | Caregiver | T0*, T1, T2 |
If NPI-Q frequency score ≥ 1 on: | ||||
“Agitation,” “motor disturbances,” “irritability,” “disinhibition” | Cohen-Mansfield Agitation Inventory [74] | Secondary outcome | Caregiver | T0, T1, T2 |
“Apathy” | Apathy Evaluation Scale-I [75] | Secondary outcome | Caregiver | T0, T1, T2 |
“Depression,” “anxiety,” “elation” | Secondary outcome | Caregiver | T0, T1, T2 | |
“Hallucinations,” “delusions” | BEHAVE-AD subscales psychosis, delusions [78] | Secondary outcome | Caregiver | T0, T1, T2 |
“Nighttime behaviors” | Sleep Disorder Inventory [79] | Secondary outcome | Caregiver | T0, T1, T2 |